South Korea's top 100 firms exhibited a combined market value of 1,745 trillion won on Thursday, up 77.5 percent from 983 trillion won five years ago amid a recent stock market rally.
According to the data from market researcher CXO Institute, the latest tally was a 43.1 percent increase from last year.
Samsung Electronics Co. remains the top-cap South Korean company with 495.5 trillion won, followed by SK hynix Inc. with 91.7 trillion won, and LG Chem Ltd. with 62.8 trillion won.
The highest on-year growth rate among the 100 firms was shown by Shinpoong Pharmaceutical Co., whose market value shoot up 1,567 percent on-year to 6.5 trillion won this year.
New entrants to the top 100 list include SK Biopharmaceuticals Co., Big Hit Entertainment, and Kakao Games Corp. The three firms made a blockbuster debut on the local bourse last year.
The South Korean stock market has been on a roll in recent months due to a growing optimism over an economic recovery.


Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Gold and Silver Prices Climb in Asian Trade as Markets Eye Key U.S. Economic Data
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Oil Prices Slip as U.S.-Iran Talks Ease Middle East Tensions
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Yen Slides as Japan Election Boosts Fiscal Stimulus Expectations
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
U.S. Stock Futures Rise as Markets Brace for Jobs and Inflation Data 



